PTN · Palatin Technologies Inc
$8.08
+0.40 (+5.21%)
At close · Jul 29
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“While the Company has raised funding in the past, the ability to raise funding in future periods is not considered probable, as defined under the accounting standards. As such, under the requirements of ASC 205-40, management may not consider the potential for future funding in their assessment of the Company's ability to meet its obligations for the next year. Based on the Company's current operating and development plans, including the ability to reduce or delay operating expenses that are within management's control, the Company expects that its existing cash and cash equivalents as of the date of this filing will be sufficient to enable it to fund operations through the next twelve months following the issuance of the financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$13.66M
Shares
1.78M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.08
Open$8.01
Day$7.61–8.51
52W$7.28–25.75
Avg vol 30d19K
Short int304K · 17.1% float · 10.5d
Short vol69%
Last earningsNov 14, 2024
DataJan 2026–Jul 2026
Filing10-Q · May 13
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−30%
below
RSI (14)
35
neutral
MACD trend
Positive
52-week position
4%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−25%
trailing
6-month return
−49%
trailing
Relative strength
−56%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
3 of 26 funds reported for Jun 30 · net +2.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
17.07% of float · ▲ +66.4% MoM · 10.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
26 holders — 13F breadth
Squeeze score
64
elevated · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
+68%
Y/Y
Free cash flow
$-21.3M
Valuation
P/E 2.1
rich
Balance sheet
$2.2M
net cash
Quant / Vol
risk profile
Volatility
124%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
11.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−30%
Bearish
RSI (14)
35
Neutral
MACD trend
Positive
Bullish
52-week position
4%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
3 of 26 funds reported for Jun 30 · net +2.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
17.07% of float · ▲ +66.4% MoM · 10.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
26 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $7
Now $8 · 4%
52-wk high $26
vs 50-day avg -30%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PTN
this stock
Palatin Technologies Inc
|
$13.66M | — | -100.0% | 2.1 | 17.1% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +7.7% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +6.6% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +4.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PTN | -0.9% | -25.1% | -49.3% | -25.1% | — |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | +1.5% | -22.8% | -55.6% | -22.8% | — |